VIR
NASDAQStockVir Biotechnology, Inc.
$9.59-0.23 (-2.39%)
52-Week Range
$4.28
$10.00
Key Stats
Market Cap
1.3B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.71
Volume
2.7M
Avg Volume
6.5M
Performance
1M
+26.23%
3M
+41.70%
6M
+97.91%
YTD
+59.60%
1Y
+29.42%
3Y
-59.69%
5Y
-81.80%
Price Chart
ETF Exposure
VIR is held by 97 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| JKJ | iShares Morningstar Small-Cap ETF | 0.02% |
| VB | Vanguard Small-Cap ETF | 0.01% |
| STSB | iShares Factors US Small Blend Style ETF | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| WSML | iShares MSCI World Small-Cap ETF | 0.01% |
| VLU | State Street SPDR S&P 1500 Value Tilt ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
| SILX | ETFMG Prime 2x Daily Junior Silver Miners ETF | 0.01% |
| VALT | ETFMG Sit Ultra Short ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.01% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.01% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.01% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DXUV | Dimensional - US Vector Equity ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| RWJ | Invesco S&P SmallCap 600 Revenue ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.00% |
| SPTM | State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| AOA | iShares Core 80/20 Aggressive Allocation ETF | 0.00% |
| AOK | iShares Core 30/70 Conservative Allocation ETF | 0.00% |
| AOM | iShares Core 40/60 Moderate Allocation ETF | 0.00% |
| AOR | iShares Core 60/40 Balanced Allocation ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| MMTM | State Street SPDR S&P 1500 Momentum Tilt ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
PreviousPage 2 of 2
About VIR ETF Exposure
Vir Biotechnology, Inc. (VIR) is held by 97 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.3B, VIR is a widely held institutional stock. The stock currently trades at $9.59. Investors can gain exposure to VIR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VIR, sorted by portfolio weight.